Agenus - Articles and news items

Phase I/II trial of INCAGN1876 in solid tumours starts

Industry news / 22 June 2016 / Victoria White, Digital Content Producer

The open-label, dose-escalation portion of the trial will evaluate the safety and tolerability of INCAGN1876 in patients with solid tumours…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+